Thao Vu and Huong Nguyen have become educational and research leaders, driven by their passion for teaching, mentorship, and scientific discovery.
The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
The issue of medicine-related harm is immense, and how to tackle it is an area of growing interest to governments and healthcare systems alike.
Recently, more than 150 first-year Monash University students travelled to Fiji for two weeks of deep cultural immersion and learning.
Medical faculties globally have been slow to recognise the training needs of the next generation of doctors regarding the health consequences of a heating planet.
Government reforms are fighting the tactics that have fed a cultural acceptability of vaping, and a mistaken belief it has insignificant health risks.
As Medicare turns 40 years old this month, it’s important to reflect on its achievements, and also what needs to be done to remodel it.
A new five-year study aims to build a broad picture of illicit drug use in regional Victoria, to better-understand the gaps in local health service planning.
The Victorian Heart Hospital, which opened in February, brings researchers to where the patients are, and already there’s a real buzz about the place.
Bee farmers discard propolis, and harvest only the honey from hives for commercial purposes, wasting its potent medicinal value. New research is changing that.
On a new episode of Monash University’s “What Happens Next?” podcast, meet the healthcare providers and advocates working tirelessly to ensure that we don't lose ground in the global fight for reproductive rights.
This week, Monash University's “What Happens Next?” podcast investigates how making reproductive healthcare inaccessible hurts us all.
It’s hoped the results of a broad, first-of-its-kind Australian government inquiry will lead to strong legal frameworks regarding abortion and contraception access.
Malaysia’s shrimp industry is big business, but unapproved antibiotic use has led to export bans and negative perceptions of the country's aquaculture industry. Can bioprospecting turn things around?
Monash University is No.1 in the world for pharmacy and pharmacology, but what does that mean, and how are the university rankings calculated?
The pandemic stretched our healthcare system to breaking point, but it also proved how new and positive models of screening and care can quickly be created in adversity.
The new Neuromedicines Discovery Centre (NDC) aims to develop psychiatric drugs and approaches to psychedelic-assisted psychotherapies for common mental illnesses.
Researchers are exploring the medical frontier of psychedelics, and their use in facilitating psychotherapy for common mental illnesses.
Could psychedelic drugs provide the next big breakthrough in psychiatry? This episode of the ‘What Happens Next?’ podcast considers the regulatory, cultural and scientific aspects of psychedelic treatment for mental illness – and how innovation in this area could improve the lives of millions of people.
A new, long-acting formulation of the medication buprenorphine promises to improve the treatment of opioid dependence.
A research project aims to boost pharmacists’ roles in neighbourhood mental health.
A new trial aims to ensure all Australian women know what is available to assist them to prevent unwanted pregnancy.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
Pharmacy students are underlining their value by taking their skills from the classroom to the COVID-19 frontline.
Dummy text
